ColoSense for colorectal cancer screening

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational post-approval study supplementing data from the CRC-PREVENT trial to measure real-world performance of the ColoSense test. Participants provide a stool sample within 120 days before undergoing a colonoscopy, and ColoSense results are compared to colonoscopy findings to calculate clinical sensitivity, specificity, positive predictive value, and negative predictive value. Adults 45 and older are the primary population for endpoint analysis, while younger enrollees may be included but not counted in primary endpoints. Individuals with prior colorectal cancer, aerodigestive tract cancer, or recent precancerous findings are excluded.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject is male or female, ≥45 years of age (subjects aged 18-45 can be enrolled onto the clinical trial but are not eligible for primary endpoint analysis)
* Subject is able to understand the study procedures, and is able to provide consent to participate in the study and authorizes release of relevant protected health information through reviewing and consenting to a HIPAA medical release form
* Subject is able and willing to provide stool samples within the 120 days prior to a colonoscopy procedure
* Subject is able and willing to undergo a colonoscopy after providing a stool sample

Exclusion Criteria:

* Subject had any precancerous findings on most recent colonoscopy. This does not include benign, and/or hyperplastic polyps of any size
* Subject has a history or diagnosis of colorectal cancer
* Subject has a history of aerodigestive tract cancer
* Subject has had a positive non-invasive screening diagnostic within the associated recommended intervals:

  * Fecal occult blood test or fecal immunochemical test within the previous twelve (12) months
  * FIT-DNA test within the previous 36 months
* Subject has had a colonoscopy in the previous nine (9) years.
* Subject has had a prior colorectal resection for any reason other than sigmoid diverticular disease
* Indication for colonoscopy was due to overt rectal bleeding, e.g., hematochezia or melena, within the previous 30 days. (Blood on toilet paper, after wiping, does not constitute rectal bleeding)
* Subject has a diagnosis or personal history of any of the following high-risk conditions for colorectal cancer:

  * Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohn's disease
  * Familial adenomatous polyposis (also referred to as "FAP", including attenuated FAP)
  * Hereditary non-polyposis colorectal cancer syndrome (also referred to as "HNPCC" of "Lynch Syndrome")
  * Other hereditary cancer syndromes including but are not limited to:

    * Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Gardner's Syndrome
    * Turcot's (or Crail's) Syndrome, Cowden's Syndrome, Juvenile Polyposis
    * Cronkhite-Canada Syndrome, Neurofibromatosis and Familial Hyperplastic Polyposis

Where it's running

• Decentralized Study
  St Louis, Missouri, United States Recruiting

Study contacts

• Study coordinator: Erica K Barnell, MD PhD
• Email: contact@geneoscopy.com
• Phone: 314-887-7777

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Parastomal Hernia After Colorectal Cancer Surgery: Do Radiology Findings Match Quality of Life

  We’re testing how often parastomal hernias appear and change on CT scans after colorectal cancer surgery with a permanent end colostomy, and whether these findings relate to patients’ quality of life.

  Recruiting Region Skane · Malmö, Skåne County · NCT07909148

• ctDNA blood test to spot buried cancer after surgery or treatment in colorectal cancer

  A blood test that looks for specific KRAS mutations in circulating tumor DNA to see if colorectal cancer has left residual disease or is likely to relapse.

  Recruiting Masaryk Memorial Cancer Institute · Brno, Czech Republic · NCT07895459

• Superior hypogastric plexus block to improve recovery after laparoscopic colorectal cancer surgery

  This will test whether adding a superior hypogastric plexus block helps adults having laparoscopic colorectal cancer surgery recover faster and have less pain.

  Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT07579780

• Comparing virtual reality and in-person art therapy for anxiety, well-being, and sleep in people with colorectal cancer

  This test will see if virtual reality art therapy or in-person art sessions can reduce anxiety and improve psychological well-being and sleep for adults with colorectal cancer receiving outpatient chemotherapy.

  Recruiting Dokuz Eylul University · Izmir, Balçova · NCT07464626

• Secondary Care Pathway Review for Colorectal Cancer

  This study looks at how the colorectal cancer pathway in secondary care is working, using routinely collected data to see how quickly people are diagnosed and treated after a positive FIT test.

  Recruiting University of Edinburgh · Edinburgh and 1 other locations · NCT07430527

• Detecting tumor DNA in small automated capillary blood samples from adults with colorectal cancer liver metastases.

  This project will try whether tiny automated capillary (finger‑prick) blood samples can detect circulating tumor DNA in adults with colorectal cancer that has spread to the liver.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland · NCT07310537

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.